Revelstoke Capital Partners completed the investment in Rarebreed.

Revelstoke Capital Partners, a healthcare private equity firm, completed the investment in Rarebreed, a technology-enabled operator of veterinary practices. Financial terms were not disclosed. Rarebreed prides itself on building trusted, lasting relationships with partner hospitals, with goals to provide top-notch patient care, world-class client service and an unparalleled work experience. Rarebreed continues to build a broad network of practices that value healthcare teams by offering them the tools necessary to grow, improve and reimagine the veterinary experience.